Predictions for a near end of the pandemic by the World Health Organization should be
interpreted with caution. Current evidence indicates that the efficacy of a fourth dose of …

The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the 29
causative pathogen of Coronavirus disease 2019 (COVID-19), has resulted in over 650 30 …

Introduction In the Northeast US, respiratory viruses such as influenza and respiratory
syncytial virus (RSV), which were largely suppressed by COVID-19-related social …

Objectives Herpesviruses are ubiquitous and after primary infection they establish lifelong
latency. The impairment of maintaining latency with short-term or long-term consequences …

Introduction Vaccination is a critical tool for preventing coronavirus disease 2019 (COVID-
19) and influenza illnesses. Coadministration of the COVID-19 vaccine, BNT162b2, with …

A lateral flow immunoassay (LFA) biosensor that allows the sensitive and accurate
identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other …

A decade-long neglect of rhinovirus as an important agent of disease in humans was
primarily due to the fact that they were seen as less virulent and capable of causing only …

Seasonal influenza is an acute respiratory infection caused by the influenza virus which
constitutes a significant public health issue associated with high morbidity and mortality. The …

Despite the availability of effective vaccines, the persistence of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) suggests that cocirculation with other pathogens …